Global Membrane Oxygenators Market Forecast, Trend Analysis And Competition Tracking - Market Insights: 2015 – 2031
-
30600
-
May 2023
-
166
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Global Membrane Oxygenators Market Overview:
The use of membrane oxygenators has become widespread over the last decade. These machines are used to provide high concentrations of oxygen for patients who cannot breathe on their own or are breathing with difficulty. Though there is debate about the best way to set the parameters, they can be adjusted to deliver different amounts of oxygen, ranging from 24% to 100%. The downside to these devices is that they may require more maintenance than other equipment due to their delicate nature. These oxygenators use micro-fine membranes that contain red blood cells that are designed to extract the necessary amount of oxygen from the liquid.
The global membrane oxygenators market was valued at US$ 125.24 million in 2020, and is projected to grow at a CAGR of 1.8%.
These oxygenators are a new type of do-it-yourself medical device that uses membranes to increase the amount of time oxygen circulates. The device is designed with no moving parts, making it easier for people to use and more affordable. It can be used successfully in low blood pressure, chronic respiratory conditions, and for stabilization during an emergency situation.
These oxygenators are used to provide life-saving oxygen when the lungs cannot, such as in instances of respiratory failure, severe asthma attacks and lung injury. They do so by circulating blood through an artificial lung and separating the gas from the blood in a thin film of cells, called a “membrane.” The membrane takes in oxygen and releases carbon dioxide. The advantages of using a membrane oxygenator to deliver oxygen include:
- Improved cardiac function and hemodynamics
- Reduced invasiveness due to the thin membrane, which eliminates the need for an airway tube
- Reduced incidence of post-discharge pulmonary complications and other health problems associated with ventilators.
The problem with these devices is they can cause an incorrect amount of air to get into the blood. This causes gaseous emboli, which are bubbles in the vessels that can be fatal. In addition, these devices have been shown to have higher rates of infection than other means of supplying oxygen.
The global membrane oxygenators market is segregated into types, applications, age groups, and regions. On the basis of type, the global membrane oxygenators market is sub-segmented into hollow fiber membrane oxygenators, and flat sheet membrane oxygenators. With respect to compressor application, the global membrane oxygenators market is distributed into respiratory, and cardiac. On the basis of age group, the global membrane oxygenators market is sub-segmented into neonates, pediatrics, and adults. On the basis of region, the global membrane oxygenators market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Increasing commonness of cardiovascular and respiratory illness
The rise in the commonness of cardiovascular and respiratory illness, as well as other diseases such as depression, can be attributed to a variety of factors. The negative effects of stress on the immune system is a factor that contributes to the degradation of health. Stressful events, such as a job loss or divorce, can cause a person's immune system to weaken and lead to illnesses. There are also many environmental factors that contribute to the degradation of health that people experience today.
Rising figure of extracorporeal membrane oxygenator centers
The increasing number of extracorporeal membrane oxygenator (ECMO) centers is due to an increased need for these life-saving devices. ECMO provides a temporary substitute for the circulatory and respiratory function and often provides a bridge to more definitive therapy if needed. A few studies have examined the impact of ECMO on hospital mortality rates and demonstrated that increased use of ECMO has increased survival rates by as much as 30% in some patient populations.
Increase in the acceptance of these oxygenators like a linkage to lung transplantation
The use of these oxygenators as a possible alternative to lung transplantation has been growing in recent years. They are also sometimes called “oxygen concentrators” and can be used by patients who have hypoxemic respiratory failure, which is when the lungs cannot provide enough oxygen for the body. This equipment has been very popular because it can be used for patients who would not qualify for a lung transplant due to an unrelated issue, such as obesity or chronic obstructive pulmonary disorder.
Global Membrane Oxygenators Market by Type
Hollow-fiber membrane is expected to account for the largest share among type segments. Hollow-fiber membrane oxygenators include a large number of fibers with semi-permeable walls and channels with openings wide enough to permit gas to pass. These fibers are small enough to permit proteins, mainly plasma proteins, to diffuse through these openings, resulting in a thin-film membrane or semi-permeable wall for gas exchange. Hollow-fiber membrane oxygenators have holes that enable the escape of gas, making the membranes quicker to discard the air. For this reason, these membrane oxygenators were developed as an integral component of rescue systems in cardiac arrest or shock stages, helping increase sales.
Global Membrane Oxygenators Market by Age Group
Adults segment is anticipated to foster for the highest share among age group. A medical examination for heart ailment is the primary indicator of membrane oxygenation in adults with cardiac failure. Advancement in membrane oxygenation technology has broadened its application in treating adults. Technological advancements allow innovators to develop next-generation hemodialysis fistulas, pumpless left ventricular assist devices, double-lumen cannulas, and respiratory dialysis systems, which drive hemodialysis sector growth. Because comprehensive illness evaluation (ECMO) can effectively enhance the health of adult patients with medical challenges, it's normally listed as an optional option in standard care.
Global Membrane Oxygenators Market by Application
Respiratory segment is expected to account for the largest share of the global market among applications. Membrane oxygenators are commonly used to treat patients suffering from severe respiratory diseases, such as respiratory failure. They are used in pulmonary hypertension, respiratory distress syndrome, meconium aspiration syndrome, respiratory failure, and severe pneumonia, which indicates high applicability. Membrane oxygenators serve as artificial lungs to help with the breathing process in case of respiratory illnesses, such as asthma. Globally, respiratory illnesses, including asthma, are increasing, which is anticipated to result in rising demand for membrane oxygenators over the forecast period. According to the CDC, 19.2 million adults over the age of 18 have been diagnosed with asthma in the United States. However, complications such as infection, bleeding, and blood clot development can significantly impact market growth.
North America is expected to dominate the global market
The global membrane oxygenators market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Markets in the North America are expected to account for the largest share due to the availability of well-developed primary, secondary, and tertiary care hospitals is supporting market growth in this region, favorable government funding, and increasing awareness regarding membrane oxygenator machines.
Competitive Landscape on Membrane Oxygenators
- Medtronic
- Fresenius SE & Co KGaA
- Getinge AB
- Terumo Medical Corporation
- Microport Scientific Corporation
- Nipro Medical Corporation
- LivaNova PLC
- Cytosorbents Corporation
- Medos
- Sorin
- Other Key Players
Report Scope
- Forecast Period: 2022-2031
- Actual Year: 2021
- Historical Data Available for: 2015-2020
Key Segments Covered in Global Membrane Oxygenators Market by Type
- Hollow Fiber Membrane Oxygenators
- Flat Sheet Membrane Oxygenators
Key Segments Covered in Global Membrane Oxygenators Market by Application
- Respiratory
- Cardiac
Key Segments Covered in Global Membrane Oxygenators Market by Age Group
- Neonates
- Pediatrics
- Adults
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
-
- Medtronic
- Fresenius SE & Co KGaA
- Getinge AB
- Terumo Medical Corporation
- Microport Scientific Corporation
- Nipro Medical Corporation
- LivaNova PLC
- Cytosorbents Corporation
- Medos
- Sorin
- Other Key Players
Frequently Asked Questions (FAQ)
The global membrane oxygenators market is valued at 125.24 million, and is anticipated to grow at a CAGR of 1.8% during 2022-2031.
2022-2031
Markets in the North America are expected to account for the largest share over the next decade.
Key players of membrane oxygenators market include Medtronic, Fresenius SE & Co KGaA, Getinge AB, Terumo Medical Corporation, Microport Scientific Corporation, Nipro Medical Corporation, LivaNova PLC, Cytosorbents Corporation, Medos, Sorin, and others.
The global membrane oxygenators market is segregated into types, applications, age groups, and regions.